Buprenorphinc was introduced asapotent, non-addictive analgesic. It is 25-50 times more potent than morphine (Jaffe et al., 1985) . It has milder euphoriant effect and minimal withdrawal symptoms. It is a partial agonist to receptors. It produces morphine-like effect at low doses and exhibits ceiling effects at doses equivalent to 30-60 mg of morphine. Because of ceiling effects the risk of overdose may be limited. For these reasons buprenorphine was thought to be "an analgesic of low abuse potential" (Jasinski et al., 1978) .
Recently it is being used in the detoxification of narcotic addiction. It has also been reported as an alternative to methadone in opiate maintenance programs. Jasinski et al. (1978) reported that buprenorphine when given chronically, blocks the subjective effects of parenteral morphine or heroin. Chronic hero : .n users sharply reduce their heroin intake when maintained on subcutaneous buprenorphine (Mello ct al., 1980) . It may be because of its both agonist and antagonist properties at the opiate receptors.
High analgesic effect, minimal withdrawal symptoms, and its efficacy in the management of narcotic addiction make it a unique drug. However, the recent experience relates a different story altogether. Buprenorphine seems to be a drug with ample potential for abuse. There are few reports of its abuse in the world literature over last 4-5 years. Paucity of reports may be due to short experience with this drug. We are reporting a case of buprenorphine abase.
CASE
A 32 years old man presented with a 13 years history of alcohol abuse, 4 years history of Pentazocin abuse and 3 years history ol Buprenorphine abuse. He had been taking later two drugs intravenously. His alcohol abuse was precipitated after a failure in love. His average daily alcohol consumption increased to 540 ml over a period of two years. He used to remain drunk for the better part of the day. He took alcohol in the morning on empty stomach, had craving for it, and used to have morning shakes. In 1984, he was introduced to injection Pentazocin. He started taking 4-10 ampules of it a day. He found it more pleasant and it did not give the "stink" of alcohol that used to "drive people away''. A year later he met with an automobile accident while under the influence ofalcohol and pentazocin. He susta : ned head injury with unconsciousness for half-an-hour. He recovered uneventfully. Subsequently, he had cough and hemoptysis and pulmo- nary tuberculosis was diagnosed. He was treated accordingly. In late 1985 he was introduced to injection buprenorphine, a "new drug" by a pharmacist who used to sell him pentazocin ampules. He liked the experience with buprenorphine. He used to take 2-1 ampules of buprenorphine along with 4-10 ampules of pentazocin and 2-4 ampules of diazepam a day intravenously. He was admitted to a psychiatric facility for a month in 1986. He was put on disulfiram. He remained abstinent from alcohol for a short time but restarted I. V-buprenorphine, pentazocin and diazepam after three months of hospita'ization. To obtain these drugs he borrowed money heavily, sold away household articles, and stole money.
He had tried morphine, pethidine, mcthaqualone and LSD also. He did not like the experience of any of these drugs. They did not "suit" h'm. He used to have very unpleasant dryness of mouth, a choking sensation in the throat, weakness, and dysphoria with morphuie and pethidine.
He was admitted to our hospital on fourteenth April, '88. He had his last injection three days ago. He was noted to have mild withdrawal features of resdessness, uneasiness, pains and aches, cold sweats, and goose flesh for next two days. He was detoxified with clonidine uneventfully. He was discharged after 41 days of hospital stay. Since then he is lost to follow up.
DISCUSSION
The pat : ent was dependent on buprenorphine and pentazocine. He had withdrawal features on stopping the abuse. It is interesting to note dysphoric reaction due to morphine and pethidine "in him. It may De due to differential effects of drugs onopiod receptors. Harper (1983) was first to report buprenorphine abuse in New Zealand. He reported that buprenorphine "can induce a state of physical dependence which leads to drugseeking behaviour even though the withdrawal syndrome is mild." In Germany, Richert ct al. (1983) reported three cares of buprenorphine dependence. These cases had no previous history of opiate addiction. They were treated lor moderate lo severe pain witli buprenorphine. Since then its abuse has been reported by various workers (Ouigley et al., 1984; Strange, 1983; Robertson et al., 1986 Robertson et al., , 1987 O'Connor et al., 1988^. Strange (1985 reported from Greater Manchester of tablets of buprenorphine being crushed and taken intravenously. He emphasized caution in the use of buprenorphine. Robertson (1986) reported buprenorphine to be the "drug of choice" abused intravenously in Edinburgh. O'Connor et al. (I988"i reported a phenomenal rise in the abuse of buprenorphine in Dublin. Over one year period it rose from nil to 89%. Decline in the purity of heroin, easy availability of buprenorphine and the fact that the tablets may be crushed and taken intravenously may be some of the reasons for increased abuse of buprenorphine.
Buprenorphine has also been reported to be psychotogenic. Paraskeviades (1988) reported near fatal auditory hallucination on taking single tablet of buprenorphine in a 50 year old man with no history of mental illness. MacEvilly el al. (1989,. reported live cases of hallucinations after epidural buprenorphine infusion. However, in litis series none of the cases seem to have genuine hallucinations. They had either nightmare, illusions or thought disorder. Yet it is evident ihat buprenorphine may cause psychotic symptoms.
In this era of substance abuse, it is a matter of genuine concern. There should be, awareness of potel tial hazards in using buprenorphine.
Opiates no matter how innocuous they look should be approached with caution. Even cough linetus containing cofleine has been reported to be addictive (Horde et al., 1988 . In the management of pain or in the detoxification of narro-tic addiction buprenorphine should be used with caution. Otherwise we may be condemned to repeat the experience with methadone. Cases of buprenorphine abuse should be actively sought for and those who are prescribed buprenorphine should be closely followed up.
